Search results
Showing 2086 to 2100 of 8933 results
Palbociclib for treating high-risk early breast cancer after neoadjuvant chemotherapy [ID3846]
Awaiting development Reference number: GID-TA10723 Expected publication date: TBC
Istradefylline with levodopa for treating motor fluctuations in Parkinson's disease [ID3868]
Awaiting development Reference number: GID-TA10773 Expected publication date: TBC
Plinabulin with docetaxel for previously treated advanced non-small-cell lung cancer [ID3895]
Awaiting development Reference number: GID-TA10776 Expected publication date: TBC
Awaiting development Reference number: GID-TA10787 Expected publication date: TBC
Netarsudil for treating open angle glaucoma or ocular hypertension [ID1078]
Awaiting development Reference number: GID-TA10431 Expected publication date: TBC
Awaiting development Reference number: GID-TA10439 Expected publication date: TBC
In development Reference number: GID-TA10446 Expected publication date: TBC
Awaiting development Reference number: GID-TA10453 Expected publication date: TBC
Ropeginterferon alfa-2b for treating polycythaemia vera without symptomatic splenomegaly [ID1596]
In development Reference number: GID-TA10497 Expected publication date: TBC
Obeticholic acid for treating liver fibrosis in people with steatohepatitis [ID1645]
In development Reference number: GID-TA10606 Expected publication date: TBC
Awaiting development Reference number: GID-TA10657 Expected publication date: TBC
Awaiting development Reference number: GID-TA10665 Expected publication date: TBC
Baloxavir marboxil for treating influenza in people at high risk of complications [ID3794]
Awaiting development Reference number: GID-TA10683 Expected publication date: TBC
Baloxavir marboxil for influenza prophylaxis in people aged 12 and over [ID3793]
Awaiting development Reference number: GID-TA10684 Expected publication date: TBC
Awaiting development Reference number: GID-TA10685 Expected publication date: TBC